• 1
    Miller MD & Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992; 12:1746.
  • 2
    Baggiolimi M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994; 55:97179.
  • 3
    Eckmann L, Jung HC, Schurer-Maly C et al. Differential cytokine expression by human intestinal epithelial cell line: regulated expression of interleukin 8. Gastroenterology 1993; 105:168997.
  • 4
    Fossiez F, Banchereau J, Murry R, Van Kooten C, Garrone P, Lebecque S. Interleukin-17. Intern Rev Immunol 1998; 16:54151.
  • 5
    Yao Z, Painter SL, Fanslow WC et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995; 155:54836.
  • 6
    Kennedy J, Rossi DL, Zurawski SM et al. Mouse IL-17: a cytokine preferentially expressed by αβ TCR+ CD4–CD8 T cells. J Interferon Cytokine Res 1996; 16:6117.
  • 7
    Albanesi C, Scarponi C, Cavani A, Federici M, Nasorri F, Girolomoni G. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-γ- and interleukin-4-induced activation of human keratinocytes. J Invest Dermatol 2000; 115:817.DOI: 10.1046/j.1523-1747.2000.00041.x
  • 8
    Shin HC, Benbernou N, Esnault S, Guenounou M. Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine 1999; 11:25766.DOI: 10.1006/cyto.1998.0433
  • 9
    Yao Z, Spriggs MK, Derry JM et al. Molecular characterization of the human interleukin (IL) -17 receptor. Cytokine 1997; 9:794800.DOI: 10.1006/cyto.1997.0240
  • 10
    Yao Z, Fanslow WC, Seldin MF et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which bind to a novel cytokine receptor. Immunity 1995; 3:81121.
  • 11
    Fossiez F, Djossou O, Chomarat P et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183:2593603.
  • 12
    Chabaud M, Fossiez F, Taupin JL, Miossec P. Enhancing effects of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 1998; 161:40914.
  • 13
    Cai XY, Gommol CPJ, Justice L, Narula SK, Fine JS. Reglation of granulocyte colony-stimulating factor gene expression by interleukin-17. Immunol Lett 1998; 62:518.DOI: 10.1016/s0165-2478(98)00027-3
  • 14
    Jovanovic DV, Di Battista JA, Martel PJ et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1β and TNF-α, by human macrophages. J Immunol 1998; 60:351321.
  • 15
    Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-γ and TNF-α. J Immunol 1999; 162:494502.
  • 16
    Awane M, Andres PG, Li DJ, Reinecker HC. NF-κB-inducing kinase is a common mediator of IL-17-, TNF-α-, and IL-1β-induced chemokine promoter actiation in intestinal epithelial cells. J Immunol 1999; 162:533744.
  • 17
    Boirivant M, Marini M, DiFelice G et al. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999; 116:55765.
  • 18
    Saubermann LJ, Probert CSJ, Christ AD et al. Evidence of T cell receptor β-chain patterns in inflammatory and noninflammatory bowel disease states. Am J Physiol 1999; 276:G613G21.
  • 19
    Kam LY & Targan SR. Cytokine-based therapies in inflammatory bowel disease. Curr Opin Gastroenterol 1999; 15:3027.
  • 20
    Dohi T, Fujihashi K, Kiyono H, Elson CO, McGhee JR. Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis. Gastroenterology 2000; 119:72433.
  • 21
    Henle G & Deinhardt F. The establishment of strains of human cells in tissue culture. J Immunol 1957; 79:549.
  • 22
    Kawanishi M. The Epstein–Barr virus latent membrane protein 1 (LMP1) enhances TNF-α-induced apoptosis of intestine 407 epithelial cells: the role of LMP1 C-terminal activation regions 1 and 2. Virology 2000; 270:25866.
  • 23
    Andoh A, Takaya H, Araki y Tsujikawa T, Fujiyama Y, Bamba T. Medium- and long-chain fatty acids differentially modulate interleukin-8 secretion in human fetal intestinal epithelial cells. J Nutr 2000; 130:263640.
  • 24
    Chomczynski P & Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:1569.DOI: 10.1006/abio.1987.9999
  • 25
    Andoh A, Takaya H, Saotome T et al. Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gastroenterology 2000; 119:2119.
  • 26
    Matsushima K, Morishita K, Yoshimura T et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988; 167:188393.
  • 27
    Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonald EJ. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 1989; 244:48793.
  • 28
    Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74:54637.
  • 29
    Dignam JP, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acids Res 1983; 11:147589.
  • 30
    Pitman RS & Blumberg RS. First line of defence: the role of the intestinal epithelium as an active component of the mucosal immune system. J Gastroenterol 2000; 35:80514.
  • 31
    Meijssen MA, Brandwein SL, Reinecker HC, Bhan AK, Podolsky DK. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2 deficient mice. Am J Physiol 1998; 274:G4729.
  • 32
    Kim J, Sanders SP, Siekierski ES, Casolaro V, Proud D. Role of NF-κB incytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol 2000; 165:338492.
  • 33
    Akira S, Isshiki H, Sugita T et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990; 9:1897906.
  • 34
    Bohmann D, Bos TJ, Admon A et al. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcriptional factor AP-1. Science 1987; 238:138692.
  • 35
    Finco TS & Baldwin AS. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 1995; 3:26372.
  • 36
    Kunsh C, Lang RK, Rosen CA, Shannon MF. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL6. J Immunol 1994; 153:15364.
  • 37
    Martin T, Cardarelli PM, Parry GC, Felts KA, Cobb RR. Cytokine induction of monocyte chemottractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κB and AP-1. Eur J Immunol 1997; 27:10917.
  • 38
    Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K. Tumor necrosis factor α and interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J Biol Chem 1992; 267:2250611.
  • 39
    Roy SK, Wachira SJ, Weihua X, Hu J, Kalvakolanu DV. CCAAT/enhancing-binding protein-β regulates interferon-induced transcription through a novel element. J Biol Chem 2000; 275:1262632. DOI: 10.1074/jbc.275.17.12626
  • 40
    Ruggiero V, Tavernier J, Fiers W, Baglioni C. Induction of the synthesis of tumor necrosis factor receptors by interferon-γ. J Immunol 1986; 136:244550.
  • 41
    Ohmori Y, Schreiber RD, Hamilton TA. Synergy between IFN-γ and TNF-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor κB. J Biol Chem 1997; 272:14899907.DOI: 10.1074/jbc.272.23.14899